SIMVASTATIN INHIBITS THE OXIDATION OF LOW-DENSITY LIPOPROTEINS BY ACTIVATED HUMAN MONOCYTE-DERIVED MACROPHAGES

被引:173
|
作者
GIROUX, LM [1 ]
DAVIGNON, J [1 ]
NARUSZEWICZ, M [1 ]
机构
[1] CLIN RES INST MONTREAL, HYPERLIPIDEMIA & ATHEROSCLEROSIS RES GRP, 110 PINE AVE W, MONTREAL H2W 1R7, QUEBEC, CANADA
关键词
SIMVASTATIN; MACROPHAGE; OXIDIZED LDL; LDL;
D O I
10.1016/0005-2760(93)90145-Y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human monocyte-derived macrophages treated with increasing concentrations of the HMG-CoA reductase inhibitor, simvastatin, showed a dose-dependent decrease in superoxide formation in response to activation by phorbol myristate acetate. As a consequence, they oxidized LDL much less than untreated cells. Addition of exogenous mevalonic acid to simvastatin-treated macrophages restored their ability for superoxide production and for oxidative modification of LDL. These results indicate that simvastatin might prevent atherosclerosis by additional mechanisms besides its hypocholesterolemic activity.
引用
收藏
页码:335 / 338
页数:4
相关论文
共 50 条
  • [1] SIMVASTATIN INHIBITS THE OXIDATION OF LOW-DENSITY LIPOPROTEINS BY ACTIVATED HUMAN MONOCYTE-DERIVED MACROPHAGES
    GIROUX, LM
    PARE, E
    DAVIGNON, J
    NARUSZEWICZ, M
    CIRCULATION, 1992, 86 (04) : 212 - 212
  • [2] COMPARATIVE INTERACTION OF GLYCATED AND OXIDIZED LOW-DENSITY LIPOPROTEINS WITH HUMAN MONOCYTE-DERIVED MACROPHAGES
    GUGLIUCCI, A
    SIFFERT, JC
    DUMONT, S
    STAHL, AJC
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 1993, 6 (01) : 51 - 57
  • [3] STIMULATION OF CHOLESTERYL ESTER SYNTHESIS IN HUMAN MONOCYTE-DERIVED MACROPHAGES BY ASIALO LOW-DENSITY LIPOPROTEINS
    TANIGUCHI, T
    ISHIKAWA, Y
    TSUNEMITSU, M
    ASAOKA, Y
    MATSUMOTO, K
    FUKUZAKI, H
    ARTERIOSCLEROSIS, 1989, 9 (05): : A767 - A767
  • [4] NATIVE LOW-DENSITY LIPOPROTEINS STIMULATE LEUKOTRIENE-B4 PRODUCTION BY HUMAN MONOCYTE-DERIVED MACROPHAGES
    NIGON, F
    ROUIS, M
    FOSTER, SJ
    CHAPMAN, MJ
    BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1083 (03) : 230 - 234
  • [5] METABOLISM OF ACETYLATED LOW-DENSITY LIPOPROTEINS BY MONOCYTE-DERIVED MACROPHAGES FROM PATIENTS WITH WERNERS SYNDROME
    MORI, S
    MORISAKI, N
    SAITO, Y
    YOSHIDA, S
    ARTERIOSCLEROSIS, 1989, 9 (05): : 644 - 649
  • [6] REGULATION OF MODIFIED LOW-DENSITY LIPOPROTEIN RECEPTORS IN HUMAN MONOCYTE-DERIVED MACROPHAGES
    MAZZONE, T
    CHAIT, A
    CLINICAL RESEARCH, 1981, 29 (02): : A415 - A415
  • [7] STIMULATION OF CHOLESTERYL ESTER SYNTHESIS IN HUMAN MONOCYTE-DERIVED MACROPHAGES BY LOW-DENSITY LIPOPROTEINS FROM TYPE-1 (INSULIN-DEPENDENT) OF LOW-DENSITY LIPOPROTEINS
    LYONS, TJ
    KLEIN, RL
    BAYNES, JW
    STEVENSON, HC
    LOPESVIRELLA, MF
    DIABETOLOGIA, 1987, 30 (12) : 916 - 923
  • [8] OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEINS INHIBIT EXPRESSION OF PLATELET DERIVED GROWTH-FACTOR BY HUMAN MONOCYTE-DERIVED MACROPHAGES
    MALDEN, LT
    ROSS, R
    CHAIT, A
    CLINICAL RESEARCH, 1990, 38 (02): : A291 - A291
  • [9] UPTAKE OF CHOLESTEROL-RICH REMNANT LIPOPROTEINS BY HUMAN MONOCYTE-DERIVED MACROPHAGES IS MEDIATED BY LOW-DENSITY LIPOPROTEIN RECEPTORS
    KOO, C
    WERNETTEHAMMOND, ME
    GARCIA, Z
    MALLOY, MJ
    UAUY, R
    EAST, C
    BILHEIMER, DW
    MAHLEY, RW
    INNERARITY, TL
    JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (05): : 1332 - 1340
  • [10] THE INFLUENCE OF OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEINS ON EXPRESSION OF PLATELET-DERIVED GROWTH-FACTOR BY HUMAN MONOCYTE-DERIVED MACROPHAGES
    MALDEN, LT
    CHAIT, A
    RAINES, EW
    ROSS, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (21) : 13901 - 13907